Damiański, P.; Białas, A.J.; Kołacińska-Flont, M.; Elgalal, A.; Jarmakowska, K.; Kierszniewska, D.; Panek, M.; Kardas, G.; Kuna, P.; Kupczyk, M.
Correction: Damiański et al. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. Biomedicines 2025, 13, 887. Biomedicines 2025, 13, 2549.
https://doi.org/10.3390/biomedicines13102549
AMA Style
Damiański P, Białas AJ, Kołacińska-Flont M, Elgalal A, Jarmakowska K, Kierszniewska D, Panek M, Kardas G, Kuna P, Kupczyk M.
Correction: Damiański et al. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. Biomedicines 2025, 13, 887. Biomedicines. 2025; 13(10):2549.
https://doi.org/10.3390/biomedicines13102549
Chicago/Turabian Style
Damiański, Piotr, Adam Jerzy Białas, Marta Kołacińska-Flont, Anna Elgalal, Katarzyna Jarmakowska, Dorota Kierszniewska, Michał Panek, Grzegorz Kardas, Piotr Kuna, and Maciej Kupczyk.
2025. "Correction: Damiański et al. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. Biomedicines 2025, 13, 887" Biomedicines 13, no. 10: 2549.
https://doi.org/10.3390/biomedicines13102549
APA Style
Damiański, P., Białas, A. J., Kołacińska-Flont, M., Elgalal, A., Jarmakowska, K., Kierszniewska, D., Panek, M., Kardas, G., Kuna, P., & Kupczyk, M.
(2025). Correction: Damiański et al. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. Biomedicines 2025, 13, 887. Biomedicines, 13(10), 2549.
https://doi.org/10.3390/biomedicines13102549
